Recession Ahead? Plus, an Obesity Breakthrough.
Jun 10, 2022•24 min
Episode description
Why Eli Lilly and Novo Nordisk are headed for weight loss riches. And a top strategist shares moves to make now.
Learn more about your ad choices. Visit megaphone.fm/adchoices
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast